Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Esophageal Cancer-Derived Organoids to Predict Patients' Treatment Response

Autor: Du, L., Nagle, P.W., van Luijk, P., Plukker, J., Muijs, C., Coppes, R.P.

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics 1 October 2023 117(2) Supplement:e227-e227

Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer

Autor: Seesing, M F J, van der Veen, A, Brenkman, H J F, Stockmann, H B A C, Nieuwenhuijzen, G A P, Rosman, C, van den Wildenberg, F J H, van Berge Henegouwen, Mark I, van Duijvendijk, P, Wijnhoven, B P L, Stoot, J H M B, Lacle, M, Ruurda, J P, van Hillegersberg, R, Baas, P C, Boerma, D, de Steur, W O, de Waard, J W D, Heisterkamp, J, van Hillo, M, Kouwenhoven, E A, Liem, M S L, van der Peet, D L, Pierie, J P E N, Plukker, J T M, Roumen, R M H, Tetteroo, G W M, van Workum, F

Publikováno v: Diseases of the esophagus, 32(12). Wiley-Blackwell
Dis Esophagus
Diseases of the Esophagus, 32(12):doz034. Wiley-Blackwell
Diseases of the Esophagus
Diseases of the Esophagus, 32(12):doz034. Wiley-Blackwell Publishing Ltd
Diseases of the Esophagus, 32
Diseases of the Esophagus, 32, 9
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 32(12). Wiley-Blackwell
Seesing, M F J, Van Der Veen, A, Brenkman, H J F, Stockmann, H B A C, Nieuwenhuijzen, G A P, Rosman, C, Van Den Wildenberg, F J H, Van Berge Henegouwen, M I, Van Duijvendijk, P, Wijnhoven, B P L, Stoot, J H M B, Lacle, M, Ruurda, J P & Van Hillegersberg, R 2020, ' Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer : A nationwide study ', Diseases of the Esophagus, vol. 32, no. 12, doz034 . https://doi.org/10.1093/dote/doz034
Diseases of the esophagus, 32(12):doz034. Wiley-Blackwell

SUMMARY The standard of care for gastroesophageal cancer patients with hepatic or pulmonary metastases is best supportive care or palliative chemotherapy. Occasionally, patients can be selected for curative treatment instead. This study aimed to eval

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc120a8b2e5541cd8361f05007a6beca
http://www.scopus.com/inward/record.url?scp=85079036588&partnerID=8YFLogxK

Impaired health in long term survivors of esophageal cancer after neo-adjuvant chemoradiotherapy?

Autor: De Groot, C., Muijs, K., Plukker, J., Van Luijk, P., Langendijk, H., Beukema, J.

Publikováno v: Radiotherapy and Oncology, 133. ELSEVIER IRELAND LTD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::4e64f46b2d41738e3d9e033662eb49a7
https://research.rug.nl/en/publications/b12bcca0-c56b-474f-b939-a2e019c1abf7

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study

Autor: Borggreve, A. S., Mook, S., Verheij, M., Mul, V. E.M., Bergman, J. J., Bartels-Rutten, A., Ter Beek, L. C., Beets-Tan, R. G.H., Bennink, R. J., Van Berge Henegouwen, M. I., Brosens, L. A.A., Defize, I. L., Van Dieren, J. M., Dijkstra, H., Van Hillegersberg, R., Hulshof, M. C., Van Laarhoven, H. W.M., Lam, M. G.E.H., Van Lier, A. L.H.M.W., Muijs, C. T., Nagengast, W. B., Nederveen, A. J., Noordzij, W., Plukker, J. T.M., Van Rossum, P. S.N., Ruurda, J. P., Van Sandick, J. W., Weusten, B. L.A.M., Voncken, F. E.M., Yakar, D., Meijer, G. J., Aleman, B. M.P., Borra, R. J.H., Van Etten, B., Gisbertz, S. S., Goense, L., Haj Mohammad, N., Hartemink, K. J., Kappert, P., Kats-Ugurlu, G., Kodach, L. L., Korteweg, T., Krishnadath, K. K., Langendijk, J. A., De Leng, W. W.J., Meijer, S. L., Potze, J. H., Stoker, J., Vegt, E., Verkooijen, H. M., Vollenbrock, S. E., Wessels, F.

Publikováno v: BMC Cancer
BMC Cancer, 18:1006. BMC
BMC Cancer, 18
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer, 18(1). BioMed Central
BMC cancer, 18(1):1006. BioMed Central

Contains fulltext : 200332.pdf (Publisher’s version ) (Open Access) BACKGROUND: Nearly one third of patients undergoing neoadjuvant chemoradiotherapy (nCRT) for locally advanced esophageal cancer have a pathologic complete response (pCR) of the pri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a9677306e8ad3f992aec10350b2bd6
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055078905&origin=inward